Hadassah

Hadassah’s Heart Institute: Innovation at the Forefront

Thursday, Jan 11 2018

Prof. Chaim Lotan

Prof. Chaim Lotan, head of the Hadassah Medical Organization’s Heart Institute, has made it a personal objective to foster innovation in cardiovascular technology.

With this objective at the forefront, the Heart Institute has initiated two programs to nurture and inspire innovators of the future. One is the Innovations in Cardiovascular Interventions (ICI) initiative, an international conference devoted to innovations in cardiovascular medicine. Launched in 2006 together with Prof. Rafael Beyar, Cardiologist and Chief Executive officer of Haifa’s Rambam Medical Center, ICI has become the premier international gathering dedicated to this topic.

The tenth anniversary of the ICI Conference was attended by 2,000 professionals from over 40 countries. One component of the conference is a day-long program developed with Prof. Paul Iaizzo, PhD, Professor of Surgery, Integrative Biology, and Physiology at the University of Minnesota, which covers the steps involved in the invention of a biomedical device and bringing it to market. During the program, groups of participants “invent” a possible solution to a specific medical need and work through the steps of bringing it to fruition, guided by experts.

The second initiative to promote innovation is an inter-faculty course in Biodesign Innovation--a collaboration between Prof. Lotan and Prof. Yaakov (Koby) Nahmias, Founding Director of the Alexander Grass Center for Bioengineering at the Hebrew University. During this yearlong, part-time program for graduate students, each young scientist participates in the development of innovative devices or systems. With the course in existence for four years now, seven of the final projects have produced marketable devices, or are in late stages of testing, supported by grants.

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Jun 12 2019

Multinational Study Reveals Reduction in Kidney Disease Progression with Diabetes Drug

In a large multinational study that revealed the effectiveness of a medicine called dapagliflozin in reducing cardiovascular death from heart failure among high-risk diabetic patients, the first sub-analysis of renal data has also identified a 47 percent drop in decline of kidney function and renal death.

READ MORE ›
alt_text

Wednesday, Jun 5 2019

What Causes PMS? Hadassah Study Offers Answer, with Implications for Future Research

A new explanation for the mood swings, irritability, and depression, known as Premenstrual syndrome (PMS) has been suggested by a Hadassah Medical Organization study.

READ MORE ›
alt_text

Wednesday, Jun 5 2019

Hadassah Confronts the Comeback of Measles

Measles, a disease we have not seen for a long time, has come back. In the past year and a half, Israel has seen over 4,000 cases, says Prof. Allon Moses, director of the Department of Clinical Microbiology and Infectious Diseases at the Hadassah Medical Organization.

READ MORE ›
alt_text

Wednesday, May 29 2019

First Cath Lab Opens in Northern Neighborhoods of Jerusalem at Hadassah Mount Scopus

Hadassah Hospital Mount Scopus inaugurated the first advanced cardiac catheterization unit serving Jerusalem’s northern neighborhoods.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More